Limited Clinical Benefit from Trastuzumab in Recurrent Endometrial Cancer

Publisher： Karger

E-ISSN： 1423-002x|67|1|46-48

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.67, Iss.1, 2008-10, pp. : 46-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Expression in Primary, Metastatic and Recurrent Lesions of Endometrial Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 48, Iss. 3, 1999-10 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Risk for Advanced-Stage Endometrial Cancer in Surgical Specimens from Patients with Complex Endometrial Hyperplasia with Atypia

By  

Gynecologic and Obstetric Investigation, Vol. 73, Iss. 1, 2011-11 ,pp. : 38-42

Karger

Access to resources Recommend Favorite

Endometrial Metastasis from Breast Cancer in a Patient Receiving Tamoxifen Therapy

By  

Gynecologic and Obstetric Investigation, Vol. 50, Iss. 2, 2000-08 ,pp. : 136-138

Karger

Access to resources Recommend Favorite

Fertility-Sparing in Endometrial Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 67, Iss. 4, 2009-03 ,pp. : 250-268

Karger

Access to resources Recommend Favorite

Characterization of Subclonal Cell Lines Showing High Motility Derived from an Undifferentiated Human Endometrial Cancer Cell Line

By  

Gynecologic and Obstetric Investigation, Vol. 48, Iss. 3, 1999-10 ,pp. : 206-210

Karger

Access to resources Recommend Favorite